Page 4 - Allurion Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allurion Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allurion Program Today - Breaking & Trending Today

Swallowable Balloon, Semaglutide Improve Obesity-Related OSA

Published: January 17, 2024

The combined therapy of a swallowable weight-loss balloon and semaglutide oral formulation showed significant reductions in OSA.

Source: sleepreviewmag.com

Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities

Published: January 11, 2024

Allurion Program led to resolution of type 2 diabetes, hypertension, and obstructive sleep apnea in just 4 months in over half of the patients treated Results improved with addition of oral GLP-1...

Source: marketscreener.com

Allurion Announces Preliminary Fourth Quarter and Full Year2023 Results and Provides 2024 Outlook

Published: January 9, 2024

NATICK - Allurion Technologies, Inc. , a company dedicated to ending obesity, today announced preliminary unaudited results for the fourth quarter and full year 2023. The Company also issued its...

Source: marketscreener.com

Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook

Published: January 8, 2024

Generated substantial procedure growth in 2023 driven by best-in-class efficacy of balloon program; prioritizing key investments in strategic markets and digital innovations ahead of FDA milestones ...

Source: marketscreener.com